Disability weights for the Global Burden of Disease 2013 study.
By J. Salomon, J. Haagsma, A. Davis, Charline Maertens de Noordhout, S. Polinder, A. Havelaar, A. Cassini, B. Devleesschauwer, Mirjam E. Kretzschmar, Niko Speybroeck and 2 more. Lancet Global Health, 2015
1,062 citations recorded by the source corpus.
BACKGROUND The Global Burden of Disease (GBD) study assesses health losses from diseases, injuries, and risk factors using disability-adjusted life-years, which need a set of disability weights to quantify health levels associated with non-fatal outcomes. The objective of this study was to estimate disability weights for the GBD 2013 study. METHODS We analysed data from new web-based surveys of participants aged 18-65 years, completed in four European countries (Hungary, Italy, the Netherlands, and Sweden) between Sept 23, 2013, and Nov 11, 2013, combined with data previously collected in the GBD 2010 disability weights measurement study. Surveys used paired comparison questions for which respondents considered two hypothetical individuals with different health states and specified which person they deemed healthier than the other. These surveys covered 183 health states pertinent to GBD 2013; of these states, 30 were presented with descriptions revised from previous versions and 18 were new to GBD 2013. We analysed paired comparison data using probit regression analysis and rescaled results to disability weight units between 0 (no loss of health) and 1 (loss equivalent to death). We compared results with previous estimates, and an additional analysis examined sensitivity of paired comparison responses to duration of hypothetical health states. FINDINGS The total analysis sample consisted of 30 230 respondents from the GBD 2010 surveys and 30 660 from the new European surveys. For health states common to GBD 2010 and GBD 2013, results were highly correlated overall (Pearson's r 0·992 [95% uncertainty interval 0·989-0·994]). For health state descriptions that were revised for this study, resulting disability weights were substantially different for a subset of these weights, including those related to hearing loss (eg, complete hearing loss: GBD 2010 0·033 [0·020-0·052]; GBD 2013 0·215 [0·144-0·307]) and treated spinal cord lesions (below the neck: GBD 2010 0·047 [0·028-0·072]; GBD 2013 0·296 [0·198-0·414]; neck level: GBD 2010 0·369 [0·243-0·513]; GBD 2013 0·589 [0·415-0·748]). Survey responses to paired comparison questions were insensitive to whether the comparisons were framed in terms of temporary or chronic outcomes (Pearson's r 0·981 [0·973-0·987]). INTERPRETATION This study substantially expands the empirical basis for assessment of non-fatal outcomes in the GBD study. Findings from this study substantiate the notion that disability weights are sensitive to particular details in descriptions of health states, but robust to duration of outcomes. FUNDING European Centre for Disease Prevention and Control, Bill and Melinda Gates Foundation.
Subfields: Geriatrics and Gerontology, Physiology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/69b309a85e82149b3c14179b0aafae6fe3865a4f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Wu
- A. Moran
- J. Carapetis
- Xuan-Qi Zheng
- Jin-feng Huang
- Xiangyang Wang
- A. Abajobir
- G. Vu
Citations in the corpus
- Global Skin Disease Morbidity and Mortality (2017, neutral): “J Eur Acad Dermatol Vene r ol 2006;20(10):1287-95.”
- Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors (2017, background): “YLDs were calculated as prevalence of each cause-specific sequela—in each age group, sex, geography, and year—times a corresponding GBD disability weight derived from a population survey of >60,000 respondents (Salomon et al. 2012; Salomon et al. 2015).”
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (2023, neutral): “36 We included estimates for four diabetic sequelae for each type of diabetes: neuropathy, diabetic foot, lower limb amputation, and vision loss due to retinopathy.”
- Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017 (2020, methodology): “The DWs were based on surveys that were conducted in a limited number of countries (Bangladesh, Indonesia, Peru, Tanzania, the USA, Hungary, Italy, The Netherlands and Sweden) prior to 2013 as well as a global web-based survey (18).”